ArticleThe journal of nutrition, health & aging2009

Challenges in the conduct of disease-modifying trials in AD: practical experience from a phase 2 trial of Tau-aggregation inhibitor therapy.

C Wischik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.